CHELMSFORD, Mass., May 14, 2020 /PRNewswire/ -- Brooks
Automation, Inc. (Nasdaq: BRKS) announced today that company
management will participate in the UBS Virtual Global Healthcare
Conference on Wednesday, May 20, 2020
at 1:20 p.m. ET. The 40-minute
session will be webcast live via the Brooks investor relations
website at www.brooks.investorroom.com/events.
About Brooks Automation
Brooks (Nasdaq: BRKS) is a
leading provider of life science sample-based solutions and
semiconductor manufacturing solutions worldwide. The
Company's Life Sciences business provides a full suite of reliable
cold-chain sample management solutions and genomic services across
areas such as drug development, clinical research and advanced cell
therapies for the industry's top pharmaceutical, biotech, academic
and healthcare institutions globally. Brooks Life Sciences'
GENEWIZ division is a leading provider of DNA gene sequencing and
gene synthesis services. With over 40 years as a partner to
the semiconductor manufacturing industry, Brooks is a provider of
industry-leading precision vacuum robotics, integrated automation
systems and contamination control solutions to the world's leading
semiconductor chip makers and equipment manufacturers. Brooks
is headquartered in Chelmsford,
MA, with operations in North
America, Europe and
Asia. For more information, visit www.brooks.com.
INVESTOR CONTACTS:
Mark Namaroff
Director, Investor Relations
Brooks Automation
978.262.2635
mark.namaroff@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.2400
sherry.dinsmore@brooks.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/brooks-to-participate-in-the-ubs-virtual-global-healthcare-conference-301059457.html
SOURCE Brooks Automation